Combination of miRNA499 and miRNA133 Exerts a Synergic Effect on Cardiac Differentiation
暂无分享,去创建一个
Antonio Zaza | Manuela Mura | Marcella Rocchetti | M. Mura | Federica Pisano | M. Ciuffreda | M. Gnecchi | M. Rocchetti | A. Zaza | F. Copes | Claudia Altomare | Massimiliano Gnecchi | L. Barile | C. Altomare | G. Viarengo | Federica Pisano | Elisabetta Cervio | Lucio Barile | Maria Chiara Ciuffreda | Giuseppe Malpasso | Francesco Copes | Patrizia Danieli | Gianluca Viarengo | P. Danieli | E. Cervio | G. Malpasso
[1] Ronald A. Li,et al. Dynamic MicroRNA Expression Programs During Cardiac Differentiation of Human Embryonic Stem Cells: Role for miR-499 , 2010, Circulation. Cardiovascular genetics.
[2] M. Latronico,et al. A lentiviral vector with a short troponin-I promoter for tracking cardiomyocyte differentiation of human embryonic stem cells , 2008, Gene Therapy.
[3] M. McBurney,et al. P19 embryonal carcinoma cells. , 1993, The International journal of developmental biology.
[4] Jian-Fu Chen,et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation , 2006, Nature Genetics.
[5] Arjun Deb,et al. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[6] Marie-José Goumans,et al. MicroRNA-1 and -499 Regulate Differentiation and Proliferation in Human-Derived Cardiomyocyte Progenitor Cells , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[7] S. Dimmeler,et al. Control of cardiovascular differentiation by microRNAs , 2010, Basic Research in Cardiology.
[8] S. Ogawa,et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. , 1999, The Journal of clinical investigation.
[9] D. Bers. Calcium cycling and signaling in cardiac myocytes. , 2008, Annual review of physiology.
[10] David M. Bodine,et al. Bone marrow cells regenerate infarcted myocardium , 2001, Nature.
[11] Joshua M Hare,et al. Enhanced Effect of Combining Human Cardiac Stem Cells and Bone Marrow Mesenchymal Stem Cells to Reduce Infarct Size and to Restore Cardiac Function After Myocardial Infarction , 2013, Circulation.
[12] J. P. Lopes,et al. [Mesenchymal stem cell therapy in heart disease]. , 2013, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.
[13] M. Gnecchi,et al. Genetic therapies for cardiovascular diseases. , 2005, Trends in molecular medicine.
[14] H. Jongsma,et al. P19 embryonal carcinoma cells: a suitable model system for cardiac electrophysiological differentiation at the molecular and functional level. , 2003, Cardiovascular research.
[15] Jing Zhang,et al. Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals , 2011, Cell Research.
[16] David A. Williams,et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts , 2004, Nature.
[17] H. Okano,et al. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. , 2004, Blood.
[18] P 19 embryonal carcinoma cells , 2007 .
[19] S. Silver,et al. Heart Failure , 1937, The New England journal of medicine.
[20] Bernadette A. Thomas,et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.
[21] K. Chien. Stem cells: Lost in translation , 2004, Nature.
[22] Zhe Han,et al. MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[23] A. Zeiher,et al. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. , 2007, European heart journal.
[24] M. Gnecchi,et al. Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy , 2008, Circulation research.
[25] R. Yeh,et al. MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. , 2008, Cell stem cell.
[26] Roberto Bolli,et al. Cell Therapy for Heart Failure: A Comprehensive Overview of Experimental and Clinical Studies, Current Challenges, and Future Directions , 2013, Circulation research.
[27] J. Ingwall,et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells , 2005, Nature Medicine.
[28] I. Sancho-Martinez,et al. Reprogramming toward heart regeneration: stem cells and beyond. , 2013, Cell stem cell.
[29] Mario Nadj,et al. AND FUTURE DIRECTIONS , 2017 .
[30] Alan W. Flake,et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep , 2000, Nature Medicine.
[31] M. Sampaolesi,et al. Altered functional differentiation of mesoangioblasts in a genetic myopathy , 2013, Journal of cellular and molecular medicine.
[32] C. Murry,et al. Heart regeneration , 2011, Nature.
[33] M. Ashraf,et al. Differentiation of Bone Marrow Stromal Cells Into the Cardiac Phenotype Requires Intercellular Communication With Myocytes , 2004, Circulation.
[34] B. Fleischmann,et al. Bone marrow–derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation , 2004, Nature Medicine.
[35] A. Malik,et al. Role of Ca2+ signaling in the regulation of endothelial permeability. , 2002, Vascular pharmacology.
[36] V. Maltsev,et al. Cardiomyocyte-like cells differentiated in vitro from embryonic carcinoma cells P19 are characterized by functional expression of adrenoceptors and Ca2+ channels , 1994, In Vitro Cellular & Developmental Biology - Animal.
[37] I. Weissman,et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium , 2004, Nature.